Pharmaceutical Industry Information Portal



Production of one of the world’s most sought-after drugs for migraine therapy starts in Moscow

The Russian pharmaceutical company NovaMedica has announced the production and market launch of the first large batch of the drug Relonova® intended for relief of migraine-associated headaches.

GMP-inspections of veterinary manufacturers in the second quarter of 2023

There are only two months left before the amendments to Federal Law No. 61-FZ of 12.04.2010 "On the Circulation of Medicines" introduced by Federal...

RNC Pharma: Pharmaceutical Drug Production in Russia (May 2023)

In January–May 2023, Russian manufacturers produced 282 billion rubles’ of pharmaceutical drugs (manufacturer’s prices, VAT included), down 5.8% from the same period in 2022.

RNC Pharma: Top 20 Online Pharmaceutical Retailers in Russia in Q1 2023

In January–March 2023, the online sales or reservations of pharmacy products (pharmaceutical drugs and parapharmaceuticals) in Russia were 80.2 billion rubles (end-user prices, VAT included), up 2.3% from January–March 2022 (against 69.6% in Q1 2022, with its rush demand).

GEROPHARM invests 2 billion roubles in medicinal product manufacture in Saint Petersburg

On June 16, GEROPHARM and the Government of Saint Petersburg at SPIEF-2023 signed a cooperation agreement to implement the investment project aimed at expanding the manufacture of medicinal products and increasing their export potential.

RNC Pharma: Top pharmacy chains in the Russian pharmaceutical retail market in Q1 2023

Market participants were significantly less active in early 2023 than during the rush demand in the spring of 2022. However, both inflation rates and stable household incomes now allow us to make optimistic industry growth forecasts, at least in the short term.

Expert Articles